Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baldus, S. E.
Right arrow Articles by Dienes, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baldus, S. E.
Right arrow Articles by Dienes, H. P.
Related Collections
Right arrow Prognostic factors
Annals of Surgical Oncology 9:887-893 (2002)
© 2002 Society of Surgical Oncology

ORIGINAL ARTICLES

Correlation of MUC5AC Immunoreactivity With Histopathological Subtypes and Prognosis of Gastric Carcinoma

Stephan E. Baldus, MD, Stefan P. Mönig, MD, Verena Arkenau, Franz-Georg Hanisch, PhD, Paul M. Schneider, MD, Juergen Thiele, MD, Arnulf H. Hölscher, MD and Hans P. Dienes, MD

From the Institute of Pathology (SEB, VA, JT, HPD), Department of Visceral and Vascular Surgery (SPM, PMS, AHH), and Center of Biochemistry (SEB, VA, JT, HPD, SPM, PMS, AHH), Medical Faculty, University of Cologne, Cologne, Germany.

Correspondence: Address correspondence and reprint requests to: S. E. Baldus, MD, Institute of Pathology, Joseph-Stelzmann-Str. 9, University of Cologne, Cologne, Germany 50931; Fax: 49-221-478-6360; E-mail: s-e.baldus{at}uni-koeln.de

Background: MUC5AC represents a mucin peptide core expressed in normal gastric epithelia. Its presence in gastric carcinomas was previously described as a characteristic of gastric differentiation.

Methods: MUC5AC reactivity was investigated by immunohistochemistry and correlated with clinicopathological variables in a large series (n = 200) of gastric carcinomas.

Results: A statistically significant association between MUC5AC positivity and parameters of cancer progression (pTNM staging and grading) could not be observed. However, MUC5AC exhibited correlations with certain subtypes of histopathological differentiation. A significant reduction of MUC5AC expression was evident in mucinous and undifferentiated carcinomas according to the World Health Organization classification, as well as in type III cancers according to the Goseki classification system. Furthermore, reduced MUC5AC reactivity (confined to up to 35% of the tumor area) was significantly correlated with an unfavorable prognosis of all patients in univariate and multivariate analysis. The same association could be observed in the subgroup of pTNM stage I patients (n = 60).

Conclusions: A significant reduction of gastric differentiation as reflected by MUC5AC immunoreactivity represents a marker of worse survival probability in gastric cancer. Finally, reduced MUC5AC positivity defines a high-risk subgroup of pTNM stage I patients.

Key Words: Mucin • MUC5AC • Monoclonal antibody • Immunohistology • Stomach • Gastric carcinoma




This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
C. M. Elso, X. Lu, C. T. Culiat, J. C. Rutledge, N. L.A. Cacheiro, W. M. Generoso, and L. J. Stubbs
Heightened susceptibility to chronic gastritis, hyperplasia and metaplasia in Kcnq1 mutant mice
Hum. Mol. Genet., November 15, 2004; 13(22): 2813 - 2821.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
A. Mitsuhashi, K. Yamazawa, Y. Nagai, N. Tanaka, H. Matsui, and S. Sekiya
Correlation Between MUC5AC Expression and the Prognosis of Patients With Adenocarcinoma of the Uterine Cervix
Ann. Surg. Oncol., January 1, 2004; 11(1): 40 - 44.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by the Society of Surgical Oncology.